Related Experiment Video
Updated: Jul 5, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Factor VIII accelerates proteolytic cleavage of von Willebrand factor by ADAMTS13
Wenjing Cao1, Sriram Krishnaswamy, Rodney M Camire
1Departments of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA.
Abstract:
Proteolytic processing of von Willebrand factor (VWF) by ADAMTS13 metalloproteinase is crucial for normal hemostasis. In vitro, cleavage of VWF by ADAMTS13 is slow even at high shear stress and is typically studied in the presence of denaturants. We now show that, under shear stress and at physiological pH and ionic strength, coagulation factor VIII (FVIII) accelerates, by a factor of approximately 10, the rate of specific cleavage at the Tyr(1605)-Met(1606) bond in VWF. Multimer analysis reveals that FVIII preferentially accelerates the cleavage of high-molecular-weight multimers. This rate enhancement is not observed with VWF predenatured with 1.5 M guanidine. The ability of FVIII to enhance VWF cleavage by ADAMTS13 is rapidly lost after pretreatment of FVIII with thrombin. A FVIII derivative lacking most of the B domain behaves equivalently to full-length FVIII. In contrast, a derivative lacking both the B domain and the acidic region a3 that contributes to the high-affinity interaction of FVIII with VWF exhibits a greatly reduced ability to enhance VWF cleavage. Our data suggest that FVIII plays a role in regulating proteolytic processing of VWF by ADAMTS13 under shear stress, which depends on the high-affinity interaction between FVIII and its carrier protein, VWF.
Insights
Coagulation factor VIII (FVIII) significantly accelerates von Willebrand factor (VWF) processing by ADAMTS13 under shear stress. This interaction is crucial for regulating VWF cleavage and maintaining normal hemostasis.
Area of Science:
- Biochemistry
- Hematology
- Molecular Biology
Background:
- Proteolytic processing of von Willebrand factor (VWF) by ADAMTS13 is essential for hemostasis.
- ADAMTS13 cleavage of VWF is inefficient in vitro, even under high shear stress, often requiring denaturants.
Purpose of the Study:
- To investigate the role of coagulation factor VIII (FVIII) in modulating VWF cleavage by ADAMTS13.
- To elucidate the mechanism and conditions under which FVIII influences VWF processing.
Main Methods:
- In vitro assays measuring VWF cleavage by ADAMTS13 under controlled shear stress.
- Multimer analysis to assess VWF integrity and processing.
- Use of modified FVIII derivatives to identify key functional domains.
Main Results:
- FVIII accelerates VWF cleavage by ADAMTS13 approximately 10-fold under physiological conditions (shear stress, pH, ionic strength).
- FVIII preferentially enhances the cleavage of high-molecular-weight VWF multimers.
- The rate enhancement is dependent on the high-affinity interaction between FVIII and VWF, specifically involving the FVIII acidic region a3.
Conclusions:
- FVIII plays a critical regulatory role in the proteolytic processing of VWF by ADAMTS13 under shear stress.
- The interaction between FVIII and VWF is key to this regulatory function, impacting VWF multimer structure and hemostasis.
- These findings reveal a novel function for FVIII in VWF processing beyond its role as a coagulation factor.
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Intracellular Signaling Affects Focal Adhesions
Some...

